Your browser doesn't support javascript.
loading
Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial.
Loibl, Sibylle; O'Shaughnessy, Joyce; Untch, Michael; Sikov, William M; Rugo, Hope S; McKee, Mark D; Huober, Jens; Golshan, Mehra; von Minckwitz, Gunter; Maag, David; Sullivan, Danielle; Wolmark, Norman; McIntyre, Kristi; Ponce Lorenzo, Jose J; Metzger Filho, Otto; Rastogi, Priya; Symmans, W Fraser; Liu, Xuan; Geyer, Charles E.
Afiliación
  • Loibl S; German Breast Group, Neu-Isenburg, Germany; Centre for Haematology and Oncology Bethanien, Frankfurt, Germany. Electronic address: sibylle.loibl@gbg.de.
  • O'Shaughnessy J; Baylor University Medical Center, Dallas, TX, USA.
  • Untch M; HELIOS Klinikum Berlin-Buch, Berlin, Germany.
  • Sikov WM; Women & Infants Hospital of Rhode Island, Providence, RI, USA.
  • Rugo HS; University of California San Francisco Hellen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
  • McKee MD; AbbVie Inc, North Chicago, IL, USA.
  • Huober J; Ulm University, Ulm, Germany.
  • Golshan M; Brigham and Women's Hospital, Boston, MA, USA.
  • von Minckwitz G; German Breast Group, Neu-Isenburg, Germany.
  • Maag D; AbbVie Inc, North Chicago, IL, USA.
  • Sullivan D; AbbVie Inc, North Chicago, IL, USA.
  • Wolmark N; National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA, USA.
  • McIntyre K; Texas Oncology, US Oncology, Dallas, TX, USA.
  • Ponce Lorenzo JJ; Alicante University General Hospital, ISABIAL, GEICAM (Spanish Breast Cancer Research Group), Alicante, Spain.
  • Metzger Filho O; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Rastogi P; National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA, USA; Magee-Womens Hospital, Pittsburgh, PA, USA.
  • Symmans WF; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Liu X; AbbVie Inc, North Chicago, IL, USA.
  • Geyer CE; National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA, USA; Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA.
Lancet Oncol ; 19(4): 497-509, 2018 04.
Article en En | MEDLINE | ID: mdl-29501363
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de la Mama Triple Negativas Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de la Mama Triple Negativas Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article Pais de publicación: Reino Unido